Powered by

Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team

Nov 20, 2018 - PR Newswire
Board and Executive Moves

PR Newswire

Oculis, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments for acute and chronic back- and front-of-the-eye diseases, announces the appointments of Fabio Baschiera PharmD, MPh, Ph.D. as Vice President of Clinical Development, and Louie-Anne Gauthier M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing.

Dr. Riad Sherif, CEO of Oculissaid: "We are delighted to welcome Fabio and Louie-Anne to the...